Proliferation of myofibroblasts in the stroma of renal oncocytoma

Cell Proliferation

Volumn 43, Issue 3, 2010, Pages 287-296

  Yen, T H ^a,b   Chen, Y ^a,b   Fu, J F ^a,b   Weng, C H ^a,b   Tian, Y C ^a,b   Hung, C C ^a,b   Lin, J L ^a,b   Yang, C W ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CALDESMON; CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DESMIN; FIBRONECTIN; KI 67 ANTIGEN; UVOMORULIN; WNT PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; MALE; MYOFIBROBLAST; ONCOCYTOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STROMA;

ADENOMA, OXYPHILIC; AGED; CELL PROLIFERATION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MYOBLASTS; NEOPLASM INVASIVENESS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951674527     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00681.x     Document Type: Article

References (45)

1. Zippel L (1942) Zur Kenntnis der Onkocyten. Virchow Arch. Pathol. Anat. Zur Kenntnis der Onkocyten. 308, 360 382.
2. Klein MJ, Valensi QJ (1976) Proximal tubular adenomas of kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm. Cancer 38, 906 914.
3. Morra MN, Das S (1993) Renal oncocytoma: a review of histogenesis, histopathology, diagnosis and treatment. J. Urol. 150, 295 302.
4. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650 1659.
5. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat. Rev. Cancer 1, 46 54.
6. Barsky SH, Green WR, Grotendorst GR, Liotta LA (1984) Desmoplastic breast carcinoma as a source of human myofibroblasts. Am. J. Pathol. 115, 329 333.
7. Sappino AP, Schurch W, Gabbiani G (1990) Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63, 144 161.
8. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat. Rev. Cancer 6, 392 401.
9. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin. Cancer Res. 8, 2912 2923.
10. Van Hoorde L, Van Aken E, Mareel M (2000) Collagen type I: a substrate and a signal for invasion. Prog. Mol. Subcell. Biol. 25, 105 134.
11. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500 503.
12. Miura S, Kodaira S, Hosoda Y (1993) Immunohistologic analysis of the extracellular matrix components of the fibrous stroma of human colon cancer. J. Surg. Oncol. 53, 36 42.
13. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P et al. (1997) Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology 26, 1458 1466.
14. Doucet C, Jasmin C, Azzarone B (2000) Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts. Oncogene 19, 5898 5905.
15. Rowley DR (1998) What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 17, 411 419.
16. Lohr M, Schmidt C, Ringel J, Kluth M, Muller P, Nizze H et al. (2001) Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 61, 550 555.
17. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G (1988) Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707 712.
18. De Wever O, Demetter P, Mareel M, Bracke M (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 123, 2229 2238.
19. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ (1999) Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274, 36505 36512.
20. Martin M, Pujuguet P, Martin F (1996) Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol. Res. Pract. 192, 712 717.
21. 2, despite establishment of chimaerism and cell proliferation in bone marrow and spleen. Cell Prolif. 41, 592 606.
22. 2 -induced acute tubular injury. Cell Prolif. 41, 575 591.
23. Yen TH, Alison MR, Cook HT, Jeffery R, Otto WR, Wright NA et al. (2007) The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment. Cell Prolif. 40, 143 156.
24. Brittan M, Chance V, Elia G, Poulsom R, Alison MR, Macdonald TT et al. (2005) A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 128, 1984 1995.
25. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556 7562.
26. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D et al. (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64, 8492 8495.
27. Guarino M (2007) Epithelial-mesenchymal transition and tumour invasion. Int. J. Biochem. Cell Biol. 39, 2153 2160.
28. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA et al. (2007) Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res. 67, 2062 2071.
29. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776 1784.
30. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF et al. (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429 438.
31. Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15, 1 12.
32. Mollmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M et al. (2006) Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc. Res. 71, 661 671.
33. Yen TH, Wright NA (2006) The gastrointestinal tract stem cell niche. Stem Cell Rev. 2, 203 212.
34. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ (1995) The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 95, 859 873.
35. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341 350.
36. Xu Q, Zhang Z, Davison F, Hu Y (2003) Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ. Res. 93, e76 e86.
37. Bentzon JF, Sondergaard CS, Kassem M, Falk E (2007) Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 116, 2053 2061.
38. Kojc N, Zidar N, Vodopivec B, Gale N (2005) Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Hum. Pathol. 36, 16 21.
39. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R (2002b) CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch. 440, 298 303.
40. Barth PJ, Ramaswamy A, Moll R (2002c) CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch. 441, 564 568.
41. Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A (2002a) CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch. 440, 128 133.
42. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39, 305 318.
43. Alison MR (1995) Assessing cellular proliferation: what's worth measuring? Hum. Exp. Toxicol. 14, 935 944.
44. Kaaijk P, Kaspers GJ, Van Wering ER, Broekema GJ, Loonen AH, Hahlen K et al. (2003) Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Br. J. Cancer 88, 775 781.
45. Hall PA, Coates PJ, Goodlad RA, Hart IR, Lane DP (1994) Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo. Br. J. Cancer 70, 244 247.